CVS (CVS Health) Marketable Securities: $2,260 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CVS CVS Health Corp CVS
75 GF Score
Price $105.91
GF Value $77.70
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is CVS Health Marketable Securities?

CVS Health CVS -0.25% 75 Marketable Securities is $2,260 Mil as of Mar. 2026. GuruFocus rates CVS with a GF Score™ of 75/100 and a GF Value™ of $77.70 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. CVS Health's Marketable Securities for the quarter that ended in Mar. 2026 was $2,260 Mil.

CVS Health's annual Marketable Securities declined from Dec. 2023 ($3,259 Mil) to Dec. 2024 ($2,407 Mil) and declined from Dec. 2024 ($2,407 Mil) to Dec. 2025 ($2,145 Mil).

CVS Health  (NYSE:CVS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

CVS Health Marketable Securities Related Terms

CVS Health Marketable Securities Historical Data

* Premium members only.

The historical data trend for CVS Health's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Health Marketable Securities Chart

CVS Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,117.00 2,778.00 3,259.00 2,407.00 2,145.00

CVS Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,578.00 2,386.00 2,134.00 2,145.00 2,260.00
CVS
75GF Score
CVS Health Corp CVS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVS Health Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $2,260 Mil mean?
CVS Health (CVS) has a Marketable Securities of $2,260 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on CVS Health and its competitors.
Is CVS Health's Marketable Securities too high?
CVS Health's current Marketable Securities is $2,260 Mil. Overall, CVS Health has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CVS Health's Marketable Securities compare to ELV and CI?
CVS Health's Marketable Securities of $2,260 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Plans company?
A good Marketable Securities depends on the Healthcare Plans industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on CVS Health and its competitors. CVS Health's current Marketable Securities is $2,260 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Health stock overvalued right now?
Based on GuruFocus' analysis, CVS Health (CVS) is currently considered Significantly Overvalued. The stock's GF Value™ is $77.70, compared to a current price of $105.91 — trading 36.3% above its estimated fair value. The current Marketable Securities is $2,260 Mil. CVS Health's overall GF Score™ is 75/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For CVS Health (CVS), the current Marketable Securities is $2,260 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVS Health (CVS) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Health stock appears to be overvalued. The current stock price of $105.91 is trading 36.3% above its estimated GF Value™ of $77.70. GuruFocus considers CVS Health to be Significantly Overvalued.

Key valuation signals for CVS:

  • Marketable Securities: $2,260 Mil
  • GF Value™: $77.70 vs. price of $105.91 (36.3% above fair value)
  • GF Score™: 75/100 with 10 warning signs

No single metric tells the full story. See the CVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVS Health Business Description

Address One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
75GF Score

Get the complete analysis for CVS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$105.91
Price
$77.70
GF Value